Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study.
Renpei KatoSei NaitoKazuyuki NumakuraShingo HatakeyamaTomoyuki KoguchiTakahiro KojimaYoshihide KawasakiShuya KandoriSadafumi KawamuraYoichi AraiAkihiro ItoHiroyuki NishiyamaYoshiyuki KojimaChikara OhyamaTomonori HabuchiNorihiko TsuchiyaWataru ObaraPublished in: International journal of clinical oncology (2022)
Upfront CN may confer survival benefit in RCC patients with IMDC intermediate and poor risk.